Copyright
©The Author(s) 2023.
World J Hepatol. Feb 27, 2023; 15(2): 255-264
Published online Feb 27, 2023. doi: 10.4254/wjh.v15.i2.255
Published online Feb 27, 2023. doi: 10.4254/wjh.v15.i2.255
Table 1 Descriptive analysis of donor organ characteristics per year, n (%)
Variable (year) | 2017 | 2018 | 2019 | 2020 | Total |
Donor's place of origin | |||||
Local | 121 (48.21%) | 180 (38.88%) | 261 (57.36%) | 257 (57.11%) | 819 (50.59%) |
Regional | 67 (26.69%) | 149 (32.18%) | 128 (28.13%) | 131 (29.11%) | 475 (29.34%) |
Nacional | 63 (25.10%) | 134 (28.94%) | 66 (14.51%) | 62 (13.78%) | 325 (20.07%) |
Gender, female | 119 (47.60%) | 193 (41.87%) | 190 (41.76%) | 174 (38.75%) | 676 (41.86%) |
Blood type (ABO system) | |||||
A | 82 (32.93%) | 150 (32.47%) | 157 (34.58%) | 168 (37.42%) | 557 (34.51%) |
B | 38 (15.26%) | 52 (11.26%) | 48 (10.57%) | 36 (8.02%) | 174 (10.78%) |
AB | 11 (4.42%) | 16 (3.46%) | 25 (5.51%) | 7 (1.56%) | 59 (3.66%) |
O | 118 (47.39%) | 244 (52.81%) | 224 (49.34%) | 238 (53.01%) | 824 (51.05%) |
Race | |||||
Black | 39 (15.54%) | 42 (9.07%) | 57 (12.53%) | 46 (10.22%) | 184 (11.37%) |
Mixed-race | 80 (31.87%) | 164 (35.42%) | 159 (34.95%) | 178 (39.56%) | 581 (35.89%) |
White | 123 (49.00%) | 253 (54.64%) | 235 (51.65%) | 223 (49.56%) | 834 (51.51%) |
Others | 9 (3.59%) | 4 (0.86%) | 4 (0.88%) | 3 (0.67%) | 20 (1.24%) |
Age (categories) | |||||
< 40 yr | 48 (19.12%) | 90 (19.44%) | 104 (22.86%) | 115 (25.56%) | 357 (22.05%) |
40 yr to 49 yr | 58 (23.11%) | 102 (22.03%) | 91 (20.00%) | 106 (23.56%) | 357 (22.05%) |
50 yr to 59 yr | 77 (30.68%) | 134 (28.94%) | 136 (29.89%) | 123 (27.33%) | 470 (29.03%) |
60 yr to 69 yr | 53 (21.12%) | 99 (21.38%) | 105 (23.08%) | 82 (18.22%) | 339 (20.94%) |
≥ 70 yr | 15 (5.98%) | 38 (8.21%) | 19 (4.18%) | 24 (5.33%) | 96 (5.93%) |
Age (yr) | 50.50 (14.52) | 50.77 (15.07) | 50.00 (14.09) | 47.85 (15.03) | 49.70 (14.74) |
ICU stay > 5 d | 105 (41.83%) | 187 (40.39%) | 178 (39.12%) | 200 (44.44%) | 670 (41.38%) |
Cause of death | |||||
Cerebrovascular accident | 175 (70.00%) | 294 (63.50%) | 298 (65.49%) | 277 (61.56%) | 1044 (64.52%) |
Trauma | 43 (17.20%) | 113 (24.41%) | 101 (22.20%) | 121 (26.89%) | 378 (23.36%) |
Hypoxia | 24 (9.60%) | 45 (9.72%) | 40 (8.79%) | 41 (9.11%) | 150 (9.27%) |
Others | 8 (3.20%) | 11 (2.38%) | 16 (3.52%) | 11 (2.44%) | 46 (2.84%) |
BMI (kg/m2) | 27.28 (5.04) | 26.65 (5.00) | 26.69 (4.57) | 26.31 (4.20) | 26.66 (4.68) |
Alcoholism | 75 (29.88%) | 148 (31.97%) | 115 (25.27%) | 103 (22.89%) | 441 (27.24%) |
Cardiorespiratory arrest | 61 (24.30%) | 99 (21.38%) | 82 (18.02%) | 77 (17.11%) | 319 (19.70%) |
Vasoactive drugs in the donor | 221 (88.05%) | 422 (91.14%) | 408 (89.67%) | 405 (90.00%) | 1456 (89.93%) |
AST (U/L)1 | 56.00 (32.00; 102.00) | 64.50 (37.00; 125.00) | 74.00 (39.00; 151.00) | 74.00 (39.40; 141.00) | 68.00 (38.00; 132.00) |
ALT (U/L)1 | 47.00 (24.00; 93.00) | 49.00 (29.00; 96.00) | 45.70 (26.00; 103.00) | 47.00 (28.00; 89.00) | 47.00 (27.00; 96.00) |
GGT (U/L)1 | 84.00 (34.00; 182.00) | 94.50 (38.55; 200.00) | 83.50 (39.00; 207.00) | 84.00 (36.00; 197.50) | 87.00 (37.00; 198.00) |
Total bilirubin (mg/dL)1 | 0.50 (0.32; 0.91) | 0.50 (0.30; 0.91) | 0.55 (0.35; 0.97) | 0.52 (0.35; 0.90) | 0.52 (0.33; 0.92) |
- Citation: Braga VS, Boteon APCS, Paglione HB, Pecora RAA, Boteon YL. Extended criteria brain-dead organ donors: Prevalence and impact on the utilisation of livers for transplantation in Brazil. World J Hepatol 2023; 15(2): 255-264
- URL: https://www.wjgnet.com/1948-5182/full/v15/i2/255.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i2.255